Yovita Hartantri

Immunogenicity and safety in healthy adults of full dose versus half doses of COVID-19 vaccine (ChAdOx1-S or BNT162b2) or full-dose CoronaVac administered as a booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in Indonesia

Eddy Fadlyana, Djatnika Setiabudi, Cissy B. Kartasasmita et al. · The Lancet Infectious Diseases · 2023 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

MDR Pathogens Organisms as Risk Factor of Mortality in Secondary Pulmonary Bacterial Infections Among COVID-19 Patients: Observational Studies in Two Referral Hospitals in West Java, Indonesia

Prayudi Santoso, Martina Sung, Yovita Hartantri et al. · International Journal of General Medicine · 2022 · 26 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17

New parameters available on Sysmex <scp>XE</scp>‐5000 hematology analyzers contribute to differentiating dengue from leptospirosis and enteric fever

Amaylia Oehadian, Meta Michels, Quirijn de Mast et al. · International Journal of Laboratory Hematology · 2015 · 23 citations

Medicine, Hematology, Infectious Diseases +16

Virological failure and drug resistance during first line anti‐retroviral treatment in Indonesia

Rudi Wisaksana, Yovita Hartantri, David van de Vijver et al. · Journal of Medical Virology · 2013 · 22 citations

Life Sciences, Infectious Diseases, Microbiology +17

Are there differences in HIV retention in care between female and male patients in Indonesia? A multi-state analysis of a retrospective cohort study

Annisa Rahmalia, Michael Holton Price, Yovita Hartantri et al. · PLoS ONE · 2019 · 15 citations · Full text

Public Health, Infectious Disease Control, Health Services Research +15